| --- | --- | --- | --- | --- | --- | --- | |--------------------|--------------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | VALUE FOCUSED PROVEN STRATEGY | | | | | | | | Q3 EARNINGS REVIEW | | | | | | | www.ringenergy.com | NYSE American: REI | | | | | | Forward-Looking Statements and Supplemental Non-GAAP Financial Measures Forward –Looking Statements This Presentation includes forward-looking statements within the meaning of Section 27A o ...

Puma Biotechnology Earnings Call Commercial Update November 7, 2024 Forward-Looking Safe-Harbor Statement This presentation contains forward-looking statements, including statements regarding commercialization of NERLYNX® and the potential indications and development of our drug candidates. All forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These s ...

Q3 2024 Investor Presentation Five9 (NASDAQ: FIVN) © 2024 Five9, Inc. All rights reserved. 2024 Five9, Inc. All rights reserved. Proprietary and confidential to Five9, Inc. Safe Harbor 2 This presentation is proprietary and is intended solely for the information of the persons to whom it is presented. Disclosure of this presentation, its contents, extracts or abstracts to third parties is not authorized without the express written permission of Five9, Inc. (the "Company"), and it may not be retained, reprod ...

INVESTOR PRESENTATION Fall 2024 LEGAL DISCLAIMER This presentation and associated commentary may contain forward-looking statements, including statements regarding expectations of future results of operations or financial performance of Doximity, market size and growth opportunities, the calculation of certain of our key financial and operating metrics, capital expenditures, plans for future operations, competitive position, technological capabilities, and strategic relationships, general business condition ...

ad NU SKIN Q3 2024 Financial Overview 1- Important Information Regarding Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and inclu ...

Q3 2024 Business update Nov 7, 2024 Safe mobility at the speed of life Safe Harbor Statements This presentation of MicroVision, Inc. ("MicroVision," "the Company," "we," or "our"), and any accompanying oral presentation, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include, among others: statements relating to expectations regarding our future growth, profit ...

Ironwood Pharmaceuticals Q3 2024 Investor Update November 7, 2024 1 | --- | --- | |--------------|-------| | | | | | | | | | | | | | | | | | | | | | | Introduction | | | | | | Matt Roache | | | | | | | | | | | | | | | | | | | 2 | Safe Harbor Statement 3 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about our ability ...

Third Quarter 2024 Earnings Supplemental November 7, 2024 Safe Harbor Statement This presentation contains, or incorporates by reference, not only historical information, but also forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. Our actual results may differ from our beliefs, expectations, estimates, projections and illustrations and, consequently, you should not rely on these forward-l ...

| --- | --- | --- | |--------------------------------|-------|-------------------------| | | | | | T | | M | | L | 7 | is MEDICAL LEAR w / ปรี่สี | | GFIGS EarningsPresentation | | | DISCLAIMER Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by FIGS, Inc. (the "Company") or any officer, director, employee, agent or advisor of the Company. This presentation does not purport to be all inclusive or to contain all of the information you may desir ...

▲AXON INVESTOR PRESENTATION AXON ENTERPRISE | NOVEMBER 2024 Safe-harbor statement Forward-looking statements in this letter include, without limitation, statements regarding: proposed products and services and related development efforts and activities; expectations about the market for our current and future products and services, including statements related to our user base and customer profiles; the impact of pending litigation; strategies and trends relating to subscription plan programs and revenues; ...